carbon monoxide has been researched along with Acute Edematous Pancreatitis in 10 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the present study was to investigate the effect of carbon monoxide (CO) released from CO‑releasing molecule 2 (CORM‑2) on mice with acute pancreatitis (AP)." | 7.91 | Carbon monoxide releasing molecule‑2 (CORM‑2)‑liberated CO ameliorates acute pancreatitis. ( Liu, Y; Qin, W; Sun, B; Wang, X; Xu, X, 2019) |
| "Furthermore, in an in vivo study using acute pancreatitis model mice as a model of an inflammatory disease, a CO-HbV treatment also tended to polarize macrophages toward an M2-like phenotype and inhibited neutrophil infiltration in the pancreas, resulting in a significant inflammation." | 5.48 | Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity. ( Maeda, H; Maruyama, T; Nagao, S; Otagiri, M; Sakai, H; Taguchi, K; Wakayama, T; Watanabe, H; Yamasaki, K; Yanagisawa, H, 2018) |
| "Severe acute pancreatitis (SAP) is an inflammatory condition which leads to a systemic inflammatory response syndrome (SIRS)." | 5.36 | Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats. ( Bai, X; Chen, H; Chen, P; Kong, R; Pan, S; Sun, B; Wang, G; Wang, S, 2010) |
| "The purpose of the present study was to investigate the effect of carbon monoxide (CO) released from CO‑releasing molecule 2 (CORM‑2) on mice with acute pancreatitis (AP)." | 3.91 | Carbon monoxide releasing molecule‑2 (CORM‑2)‑liberated CO ameliorates acute pancreatitis. ( Liu, Y; Qin, W; Sun, B; Wang, X; Xu, X, 2019) |
| "Arterial blood gas levels, lung volumes, and diffusing properties for carbon monoxide were measured in 22 patients with uncomplicated acute pancreatitis who had no clinical or radiographic evidence of pulmonary involvement." | 3.66 | Impairment of pulmonary function in acute pancreatitis. ( De Troyer, A; Englert, M; Naeije, R; Yernault, JC, 1978) |
| " Although the effectiveness of HbVs, including their physicochemical characteristics and pharmacological effects, has been reported, data on the pharmacokinetic properties of HbVs are limited." | 2.58 | [Safety Evaluation of Cellular-type Artificial Blood Based on Pharmacokinetic Analysis and Its Use in Medical Gas Delivery]. ( Taguchi, K, 2018) |
| "Hydrogen sulfide displays a dual role in the mechanism of AP according to its concentration in the system." | 2.50 | From nitric oxide to hyperbaric oxygen: invisible and subtle but nonnegligible gaseous signaling molecules in acute pancreatitis. ( Dong, DL; Iv, JC; Li, L; Sun, B; Wang, G; Wu, LF, 2014) |
| "Furthermore, in an in vivo study using acute pancreatitis model mice as a model of an inflammatory disease, a CO-HbV treatment also tended to polarize macrophages toward an M2-like phenotype and inhibited neutrophil infiltration in the pancreas, resulting in a significant inflammation." | 1.48 | Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity. ( Maeda, H; Maruyama, T; Nagao, S; Otagiri, M; Sakai, H; Taguchi, K; Wakayama, T; Watanabe, H; Yamasaki, K; Yanagisawa, H, 2018) |
| "Severe acute pancreatitis (SAP) is an inflammatory condition which leads to a systemic inflammatory response syndrome (SIRS)." | 1.36 | Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats. ( Bai, X; Chen, H; Chen, P; Kong, R; Pan, S; Sun, B; Wang, G; Wang, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Zhang, R | 1 |
| Hu, G | 1 |
| Zhu, HH | 1 |
| Gao, WQ | 1 |
| Xue, J | 2 |
| Taguchi, K | 2 |
| Nagao, S | 1 |
| Maeda, H | 1 |
| Yanagisawa, H | 1 |
| Sakai, H | 1 |
| Yamasaki, K | 1 |
| Wakayama, T | 1 |
| Watanabe, H | 1 |
| Otagiri, M | 1 |
| Maruyama, T | 1 |
| Liu, Y | 1 |
| Wang, X | 1 |
| Xu, X | 1 |
| Qin, W | 1 |
| Sun, B | 3 |
| Habtezion, A | 2 |
| Wang, G | 2 |
| Iv, JC | 1 |
| Wu, LF | 1 |
| Li, L | 1 |
| Dong, DL | 1 |
| Chen, P | 1 |
| Chen, H | 1 |
| Pan, S | 1 |
| Kong, R | 1 |
| Bai, X | 1 |
| Wang, S | 1 |
| Kwan, R | 1 |
| Akhtar, E | 1 |
| Wanaski, SP | 1 |
| Collins, SD | 1 |
| Wong, RJ | 1 |
| Stevenson, DK | 1 |
| Butcher, EC | 1 |
| Omary, MB | 1 |
| Schwer, CI | 1 |
| De Troyer, A | 1 |
| Naeije, R | 1 |
| Yernault, JC | 1 |
| Englert, M | 1 |
3 reviews available for carbon monoxide and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
[Safety Evaluation of Cellular-type Artificial Blood Based on Pharmacokinetic Analysis and Its Use in Medical Gas Delivery].
Topics: Acute Disease; Animals; Blood Substitutes; Carbon Monoxide; Disease Models, Animal; Drug Carriers; D | 2018 |
From nitric oxide to hyperbaric oxygen: invisible and subtle but nonnegligible gaseous signaling molecules in acute pancreatitis.
Topics: Acute Disease; Animals; Carbon Monoxide; Gases; Humans; Hydrogen; Hydrogen Sulfide; Hyperbaric Oxyge | 2014 |
Carbon monoxide and the pancreas.
Topics: Animals; Carbon Monoxide; Heme Oxygenase (Decyclizing); Humans; Hyperglycemia; Pancreas; Pancreatiti | 2012 |
7 other studies available for carbon monoxide and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Carbon Monoxide Impairs CD11b
Topics: Animals; Antigens, Ly; Carbon Monoxide; CD11b Antigen; Cell Movement; Chemokine CCL2; Disease Models | 2018 |
Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity.
Topics: Animals; Anti-Inflammatory Agents; Biomimetics; Carbon Monoxide; Cell Line; Cytokines; Disease Model | 2018 |
Carbon monoxide releasing molecule‑2 (CORM‑2)‑liberated CO ameliorates acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Carbon Monoxide; Ceruletide; Cytokines; Disease Models, Animal; In | 2019 |
Carbon monoxide-based therapy ameliorates acute pancreatitis via TLR4 inhibition.
Topics: Acute Disease; Adoptive Transfer; Animals; Carbon Monoxide; Cells, Cultured; Female; Humans; Inflamm | 2014 |
Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats.
Topics: Animals; Carbon Monoxide; Cholagogues and Choleretics; Cytokines; Heme Oxygenase-1; Male; NF-kappa B | 2010 |
Panhematin provides a therapeutic benefit in experimental pancreatitis.
Topics: Acute Disease; Animals; Arginine; Carbon Monoxide; Chemokine CXCL1; Cytokines; Disease Models, Anima | 2011 |
Impairment of pulmonary function in acute pancreatitis.
Topics: Acute Disease; Adult; Carbon Dioxide; Carbon Monoxide; Female; Humans; Lung; Lung Volume Measurement | 1978 |